List view / Grid view

Dr Henry (Hank) Chilton (CEO of TauGen and CereMark Pharma)

 

news

New patent for traumatic brain injury drug announced

Drug discovery company, TauGen, has filed a US patent application…

12 August 2025 | By

Drug discovery company, TauGen, has filed a US patent application for a new series of drug candidates targeting endoplasmic reticulum (ER) stress – a key factor in secondary brain injury following traumatic brain injury (TBI).